首页> 外文期刊>Addiction >Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial.
【24h】

Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial.

机译:改善获取途径和更多选择尼古丁替代疗法是否会影响戒烟成功?随机对照试验的发现。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: To determine the effect of offering smokers who want to quit easy access to nicotine replacement therapy (NRT), a period of familiarization and choice of product on smoking abstinence at 6 months. DESIGN: Single-blind, randomized controlled trial. SETTING: New Zealand. PARTICIPANTS: A total of 1410 adult smokers who called the national Quitline for quitting support were randomized to usual Quitline care or a box containing different NRT products (patch, gum, inhaler, sublingual tablet, oral pouch) to try for a week prior to quitting, and then to choose one or two of these products for 8 weeks' use. MEASUREMENTS: The primary outcome was 7-day point prevalence smoking abstinence 6 months after quit day. Secondary outcomes included continuous abstinence, cigarette consumption, withdrawal, NRT choice and serious adverse events at 1 and 3 weeks and 3 and 6 months. FINDINGS: No differences in 6-month quit rates (7-day point prevalence or continuous abstinence) were observed between the groups. However, smokers allocated to the intervention group were more likely to have quit smoking at 3 months [self-reported point prevalence, relative risk (RR)=1.17, 95% confidence interval (CI): 1.02, 1.35, P=0.03], had a longer time to relapse (median 70 days versus 28 days, P<0.01) and used significantly more NRT. The selection box concept was highly acceptable to users, with the patch and inhaler combination the most popular choice (34%). CONCLUSIONS: In terms of smoking abstinence at 6 months, offering smokers who want to quit free access to a wide range of nicotine replacement therapy, including a 1-week period of familiarization and choice of up to two products, appears no different to offering reduced cost and choice of nicotine replacement therapy, with no familiarization period. This trial is registered with the Australasian Clinical Trials Network Number: ACTRN 12606000451505.
机译:目的:确定为希望戒烟的吸烟者提供便捷的尼古丁替代疗法(NRT)的效果,一段熟悉的时期并选择6个月的戒烟产品。设计:单盲,随机对照试验。地点:新西兰。参与者:总共1410名打电话给国家戒烟热线以寻求戒烟支持的成年吸烟者被随机分配到常规戒烟热线护理或一个装有不同NRT产品(贴剂,口香糖,吸入器,舌下片剂,口服袋)的盒子,尝试戒烟前一个星期。 ,然后选择其中一种或两种产品使用8周。测量:主要结果是戒烟日后6个月戒烟7天的流行率。次要结果包括持续禁酒,吸烟,戒断,选择NRT和在1、3周和3、6个月时出现严重不良事件。结果:两组之间的6个月戒烟率(7天患病率或持续禁欲)没有差异。但是,被分配到干预组的吸烟者在3个月时更容易戒烟[自我报告的点患病率,相对风险(RR)= 1.17,95%置信区间(CI):1.02、1.35,P = 0.03],复发时间更长(中位时间为70天,相比28天为P <0.01),并且使用了更多的NRT。选择盒的概念非常受用户接受,贴片和吸入器组合是最受欢迎的选择(34%)。结论:就戒烟6个月而言,为希望戒烟的吸烟者免费提供广泛的尼古丁替代疗法,包括为期1周的熟悉期和最多两种产品的选择,与减少吸烟量似乎没有什么不同。费用和尼古丁替代疗法的选择,无需熟悉期。该试验已在澳大利亚临床试验网络中注册:ACTRN 12606000451505。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号